PlainPharmaWatch

CMS Open Payments · Program Year 2024

Missouri

Missouri received $121,923,017.16 in pharmaceutical-industry payments to 14,854 physicians and 26 teaching hospitals across 337,055 transactions.

$121.9M
Total payments
$51.0M
To physicians
$66.2M
To teaching hospitals
#7
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $121.9M in payments to 14,854 physicians and 26 teaching hospitals in Missouri. That ranks Missouri #7 of 59 states and territories (0.9% of the US total), averaging $3.4K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Missouri pairs top-quartile payment volume with a balanced mix between physicians and hospitals.

#7
of 59 states
0.9%
of the national total
41.8%
to physicians vs. hospitals
14,854
physicians paid

What the Data Shows for Missouri

Missouri's Open Payments file is hospital-weighted: 54.3% of $121.9M went to 26 teaching hospitals ($2.5M each), with 41.8% on 14,854 physicians.

On the national dollar ranking it is still #7 of 59 (0.9% of US payments). Average transaction $361.73. Leading nature of payment: "Compensation for Services Other Than Consulting" at $75.6M (62.0% of the state file; top-three natures 84.5%).

Missouri sits in the 90th percentile (top-10 nationally). Just above: New York ($216.8M). Just below: Illinois ($120.3M). For context: top-ranked California ($342.4M) is 2.8× larger than Missouri. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Missouri are distributed between physicians and teaching hospitals.

Physician Payments

$51.0M

41.8% of total · 14,854 recipients · $3.4K avg

Teaching Hospital Payments

$66.2M

54.3% of total · 26 hospitals · $2.5M avg

Payment Breakdown by Type

Missouri has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 62.0%.

Nature concentration in Missouri

Top three Open Payments natures are 84.5% of state dollars; residual is every other reported nature

Compensation for Services Ot…$75.6MRoyalty or License$17.0MConsulting Fee$10.5MAll other natures (13)$18.9M

Payment categories in Missouri

Top categories by total reported dollar volume

1. Compensation for Services…$75.6M2. Royalty or License$17.0M3. Consulting Fee$10.5M4. Food and Beverage$8.5M5. Travel and Lodging$4.4M6. Education$1.6M7. Grant$1.3M8. Honoraria$1.0M9. Compensation for Faculty …$892.4K10. Long-Term Medical Supply…$663.9K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $75.6M 4,803
Royalty or License $17.0M 341
Consulting Fee $10.5M 3,508
Food and Beverage $8.5M 308,955
Travel and Lodging $4.4M 13,291
Education $1.6M 4,217
Grant $1.3M 169
Honoraria $1.0M 344
Compensation for Faculty or Speaker (Medical Education) $892.4K 351
Long-Term Medical Supply or Device Loan $663.9K 202
Debt Forgiveness $285.7K 99
Space Rental or Facility Fees $164.1K 97
Gift $98.3K 585
Entertainment $11.9K 77
Charitable Contribution $2.7K 10
Acquisitions $2.5K 6

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Missouri totals can and cannot tell you

The aggregate payment figure for Missouri measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Missouri's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.